Category: Biopharmaceuticals
Europe Biopharmaceuticals
-
Anti-Obesity Drugs Market by Type of Molecule (Biologics and Small Molecules), Active Compound Used (Tirzepatide, Semaglutide, Retatrutide, Survodutide, Cagrilintide and Semaglutide, Orforglipron, Liraglutide and Other Active Compounds), Mechanism of Action (GLP-1 Agonist / GIP Agonist, GLP-1 Agonist / GCGR Agonist, GLP-1 Agonist, GLP-1 Agonist / Amylin Analogue, GLP-1 / GCGR / GIP Agonist and Other Mechanisms of Action), Type of Agonist (Single-Agonist, Dual-Agonist and Tri-Agonist), Action Pathway (Centrally Acting, Peripherally Acting and Centrally Acting, and Peripherally Acting), Route of Administration (Oral and Parenteral), Geographical Regions (North America, Europe, Asia-Pacific and Latin America), Sales Forecast and Key Players: Industry Trends and Global Forecasts, till 2035
... CAGR of 21. 1% during the forecast period, till 2035. The opportunity for anti-obesity drugs market has been distributed across the following segments: Type of Molecule Biologics Small Molecules Active Compound Used Tirzepatide Semaglutide Retatrutide ... Read More
-
2025 Germany Biologics Contract Development Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates on equipment ... Read More
-
2025 United Kingdom Biologics Contract Development Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... the Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates on ... Read More
-
2025 Europe Biologics Contract Development Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates on equipment ... Read More
-
US and Europe Pharma and Biotech Cro Market Research Report by Service Type (Clinical Development Services, Formulation Development Services, Pharmacovigilance Services, Laboratory Services, Consulting Services, Data Management Services, and Others), by Phase {Based on phase, the US and Europe Pharma and Biotech CRO Market has been segmented into Phase I, Phase II, Phase III, Phase IV. and Post Marketing Studies (PMS)}, by Indication 9 Based on Indication, the US and Europe Pharma and Biotech CRO Market has been segmented into cardiovascular, oncology, dermatology, gynecology, neurology, respiratory diseases, orthopedics, ophthalmology and others), by End User (Pharmaceutical Companies, and Biopharmaceutical Companies) Industry Forecast to 2032
... pharmaceutical and biotechnology industries by providing outsourced services such as drug development, clinical trials, regulatory affairs, and more. These include drug development, clinical trials, regulatory affairs, and post-market surveillance. CROs help streamline the drug development ... Read More
-
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry and Non-Industry), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America (US, Canada and Mexico), Europe (Austria, France, Germany, Italy, Spain, Switzerland, UK and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific) and Rest of the World (Argentina, Brazil, Iran, Israel and Other Countries)): Industry Trends and Gl
... (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry ... Read More
-
2024 Germany Bio-Pharma Logistics Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
Biologics Contract Manufacturing Market by Type of Service(s) Offered (API, FDF), Type of Biologic Manufactured (Antibodies, Cell Therapies, Vaccines and Other Biologics), Type of Expression System Used (Mammalian, Microbial and Others), Scale of Operation (Preclinical / Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and MENA): Industry Trends and Global Forecasts, Till 2035
... / Clinical and Commercial), Company Size (Small, Mid-sized, and Large and Very Large), and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America and MENA): Industry Trends and Global Forecasts, Till 2035 BIOLOGICS CONTRACT MANUFACTURING ... Read More
-
2024 France Single-Use Bioprocessing Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 Germany Single-Use Bioprocessing Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
2024 United Kingdom Single-Use Bioprocessing Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Europe Single-Use Bioprocessing Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales ... Read More
-
Biologics Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global biologics contract manufacturing market is set for remarkable growth, with worldwide revenue anticipated to increase from USD 16.01 billion in 2024 to an impressive USD 36.3 billion by 2031. Projected to grow at ... Read More
-
Wireless Power Transmission Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 6.0% during 2025-2034. This report on global wireless power transmission market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of ... Read More
-
2024 Germany Biologics Contract Manufacturing Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published ... Read More
-
2024 United Kingdom Biologics Contract Manufacturing Forecast (2025-2030 Outlook)-Market Opportunities Report
... Healthcare industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are ... Read More
-
2024 France Biologics Contract Manufacturing Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published ... Read More
-
2024 Europe Biologics Contract Manufacturing Forecast (2025-2030 Outlook)-Market Opportunities Report
... industry. market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published ... Read More
-
Europe Bioprocessing Market Forecast to 2031 - Regional Analysis - by Product (Instruments and Consumables & Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others)
... Recombinant Protein, Cell & Gene Therapy, and Others), and End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others) The Europe bioprocessing market was valued at US$ 6,216.50 million in 2023 and is expected to reach ... Read More
-
Gastroenterology Market, By Drug Type (Biologics/Biosimilars, Antacids, Laxatives, Antidiarrheal Agents, Antiemetics, Antiulcer Agents, Others), By Dosage Form (Oral, Parenteral, Others), By Disease Type (Inflammatory Bowel Diseases (IBD), Crohn\'s Disease, Ulcerative Colitis, Irritable Bowel Syndrome (IBS), Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Gastroesophageal Reflux Disease, Liver Diseases, Colorectal Cancer, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Global gastroenterology market growth is ... Read More
-
Pegfilgrastim Biosimilars Market, By Product (Pegfilgrastim Biosimilars and Pegfilgrastim Reference Product), By Application (Oncology, Chronic Neutropenia, Stem Cell Transplantation, Others), By Route of Administration (Subcutaneous and Intravenous), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Pegfilgrastim is a long-acting form of filgrastim that stimulates the bone marrow to produce more white blood cells. Pegfilgrastim biosimilars are ... Read More
-
Biosimilars Market, By Drug Class (Recombinant Human Growth Hormone, Granulocyte Colony-Stimulating Factor, Insulin, Anticoagulants, Fusion Proteins Erythropoietin, Monoclonal Antibodies, Follitropin, Others), By Therapy Type (Oncology, Immunology, Hematology, Hormone Therapy, Metabolic Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Global biosimilars market growth is driven by rising healthcare costs worldwide and the expiration of blockbuster ... Read More
-
Healthcare Distribution Market, By Product Type (Pharmaceutical Product Distribution Services, Biopharmaceutical Product Distribution Service, and Medical Devices Distribution Services), By End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Europe, Asia Pacific, Middle East & Africa) Rising geriatric population, increasing prevalence of chronic diseases, and growing need for improved logistics in healthcare industries boosts demand for effective distribution of pharmaceuticals and medical supplies. Various ... Read More
-
Cell Cryopreservation Market, By Product Type (Cryoprotectant Agents and Equipment), By Application (Stem Cells, Oocytes and Embryotic cells, Sperm Cells, Hepatocytes, Others), By End User (Biopharmaceutical & Pharmaceutical Companies, Research Institutes, Biobank, IVF clinics, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Cell cryopreservation involves preserving cells by cooling them to extremely low temperatures, usually -80°C or below using liquid nitrogen. It helps to ... Read More
-
Downstream Processing Market, By Technique (Purification Techniques, Solid-Liquid Separation, and Clarification/Concentration), By Product (Chromatography Columns and Resins, Filters, Evaporators, Centrifuges, and Other Products), By Application (Antibodies Production, Vaccines Production, Insulin Production, and Other Applications), By End User (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutes, CROs, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... End User (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutes, CROs, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) Downstream processing refers to the purification and recovery steps in bioprocessing undertaken ... Read More
Research Assistance
